N/A N=110 Randomized Triple-blind Supportive Care

Postoperative Pain Control for Prostatectomy

Prostate Cancer

Bottom Line

View on ClinicalTrials.gov: NCT00913068 ↗

Enrolled (actual)

110

Serious AEs

0.0%

Results posted

Oct 2021

Primary outcome: Primary: Total Milligrams of Opiates — 5.15; 2.52 mg — p=0.0012

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Transverse Abdominal Plan (TAP) (Procedure); standard post op pain control (Procedure)
Age: Pediatric, Adult, Older Adult
Sex: Male
Sponsor: Nova Scotia Health Authority
Primary completion: Sep 2011

Outcome Measures

Outcome	Result	p-value
PRIMARY Total Milligrams of Opiates	5.15; 2.52	0.0012 sig

Summary

The researchers propose to investigate a relatively new anesthetic procedure, in order to maximize patient comfort and minimize the use of narcotics after a radical prostatectomy.

Eligibility Criteria

Inclusion Criteria

prostate cancer for radical prostatectomy

Exclusion Criteria

chronic pain or opiate use

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00913068). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.